We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

127 hedge funds and large institutions have $749M invested in AnaptysBio in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 42 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

124% more call options, than puts

Call options by funds: $673K | Put options by funds: $300K

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

4% more funds holding

Funds holding: 122 → 127 (+5)

4% more capital invested

Capital invested by funds: $720M → $749M (+$28.4M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.88% less ownership

Funds ownership: 101.54% → 100.67% (-0.88%)

29% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 42

Holders
127
Holders Change
+5
Holders Change %
+4.1%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
30
Reduced
42
Closed
9
Calls
$673K
Puts
$300K
Net Calls
+$373K
Net Calls Change
+$1.05M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$12M
2
Blackstone Inc
Blackstone Inc
New York
+$8.34M
3
GPP
Great Point Partners
Connecticut
+$3.79M
4
EP
Eversept Partners
New York
+$1.98M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$1.29M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$12M
2
State Street
State Street
Massachusetts
-$8M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.95M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$2.52M
5
Morgan Stanley
Morgan Stanley
New York
-$2.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$3.93M -$1.61M -63,610 -30%
Charles Schwab
27
Charles Schwab
California
$3.68M -$182K -7,189 -5%
Millennium Management
28
Millennium Management
New York
$3.6M +$639K +25,189 +23%
Los Angeles Capital Management
29
Los Angeles Capital Management
California
$3.54M +$111K +4,355 +3%
SG Americas Securities
30
SG Americas Securities
New York
$3.52M +$307K +12,088 +10%
Massachusetts Financial Services
31
Massachusetts Financial Services
Massachusetts
$2.61M -$32K -1,262 -1%
Macquarie Group
32
Macquarie Group
Australia
$2.56M – – –
Jacobs Levy Equity Management
33
Jacobs Levy Equity Management
New Jersey
$2.4M -$18.7K -738 -0.8%
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.38M +$196K +7,733 +10%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.23M +$80.8K +3,185 +4%
EP
36
Eversept Partners
New York
$2.12M +$1.98M +78,054 New
Morgan Stanley
37
Morgan Stanley
New York
$1.95M -$2.28M -89,729 -55%
Renaissance Technologies
38
Renaissance Technologies
New York
$1.86M -$3.95M -155,600 -69%
Wells Fargo
39
Wells Fargo
California
$1.74M -$399K -15,717 -20%
JAM
40
Jupiter Asset Management
United Kingdom
$1.6M – – –
PPA
41
Parametric Portfolio Associates
Washington
$1.55M +$166K +6,544 +13%
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$1.35M +$1.29M +50,660 New
Fisher Asset Management
43
Fisher Asset Management
Washington
$1.25M +$1.17M +46,019 New
Ensign Peak Advisors
44
Ensign Peak Advisors
Utah
$1.18M +$1.1M +43,442 New
Axa
45
Axa
France
$1.07M – – –
Swiss National Bank
46
Swiss National Bank
Switzerland
$1.06M – – –
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$1.02M -$1.34K -53 -0.1%
AA
48
ALPS Advisors
Colorado
$912K -$61.5K -2,422 -7%
MAM
49
Martingale Asset Management
Massachusetts
$910K +$350K +13,800 +70%
ZCM
50
Ziegler Capital Management
Illinois
$901K +$843K +33,205 New
1
2
3 4 5

ANAB Hedge Fund Activity: Q3 2021 in Review

127 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q3 2021, worth a combined $749M — up 3.9% from $720M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ANAB positions and 9 closed out — a net gain of 6 holders — while 30 added to existing stakes and 42 trimmed.

The largest buyer was Woodline Partners, adding an estimated $12M. The largest seller was BVF Inc, cutting an estimated $12M.

  • 127 institutional investors held AnaptysBio (ANAB) as of Q3 2021, up from 122 in Q2 2021.
  • Funds reported $749M of AnaptysBio stock for Q3 2021, up 3.9% quarter-over-quarter.
  • 15 funds opened new AnaptysBio positions in Q3 2021 and 9 closed out, a net change of +6 holders.
  • The largest AnaptysBio buyer in Q3 2021 was Woodline Partners, an estimated $12M added.
  • The largest AnaptysBio seller in Q3 2021 was BVF Inc, an estimated $12M sold.

Based on aggregated 13F filings for Q3 2021.